Cirrus Bio, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Cirrus Bio, Inc. - overview

Established

2021

Location

Phoenix, AZ, US

Primary Industry

Healthcare

About

Based in Arizona, US, and founded in 2021 by co-founders David Mallery (CEO) and Scott Morris, Cirrus Bio, Inc. operates as a provider of diagnostic solutions for early disease management using AI and multi-omics technology to treat oncology diseases. In March 2024, Maverix Medical, LLC, a portfolio company of KKR, acquired Cirrus Bio, Inc. The company provides a wide range of medical diagnostic products, such as artificial intelligence-based tools, to help detect diseases early on for better treatment outcomes.


Additionally, the firm also offers services such as clinical testing and product commercialization support.


Current Investors

Maverix Medical, LLC

Primary Industry

Healthcare

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Medical Software

Website

www.cirrus.bio/

Verticals

Artificial Intelligence, Cloud Computing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Cirrus Bio, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedCirrus Bio, Inc.-

Displaying 1 - 1 of 1

Cirrus Bio, Inc. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.